PUBLISHER: Orion Market Research | PRODUCT CODE: 1064773
PUBLISHER: Orion Market Research | PRODUCT CODE: 1064773
Global Attention deficit hyperactivity disorder drug market Size, Share & Trends Analysis Report By Drug Type (Stimulants, Non-stimulants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, e-Commerce) by Age Group (Children and Adults), and Forecast (2020-2026)
The global attention deficit hyperactivity disorder drug market is anticipated to grow at a considerable CAGR during the forecast period. The increase in the number of pre-term deliveries of newborns is contributing the growth of the global attention deficit hyperactivity disorder drug market. According to the University of Maryland Medical Center (UMMC), this disease affects 20% of prematurely born babies currently. Governments across the globe are paying attention to the growing number of people suffering from a number of psychological disorders, including attention deficit hyperactivity disorder (ADHD). This focus of government towards treatment of such disease is further likely to drive the global market.
The global attention deficit hyperactivity disorder drug market is segmented based on drug type, distribution channel, and age group. Based on drug type, the attention deficit hyperactivity disorder drug market is segmented into stimulants and non- stimulants. Based on distribution channel, the attention deficit hyperactivity disorder drug market is segmented into hospital pharmacies, retail pharmacies, and e-commerce. Based on age group, the attention deficit hyperactivity disorder drug market is segmented into children and adults.
Geographically, the global attention deficit hyperactivity disorder drug market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global attention deficit hyperactivity disorder drug market include Pfizer Inc., Eli Lilly and Company., Novartis AG., GlaxoSmithKline PLC., Mallinckrodt Pharmaceuticals., Hisamitsu Pharmaceutical Co., Inc., and Johnson & Johnson., among others.
Market Segmentation
The Report Covers